{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:22:15Z","timestamp":1788283335697,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00428-023-03570-1","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:46:34Z","timestamp":1687607194000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations"],"prefix":"10.1007","volume":"483","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6693-1989","authenticated-orcid":false,"given":"Pooja","family":"Navale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyali","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Trikalinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"issue":"10","key":"3570_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3(10):1335\u20131342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"3570_CR2","doi-asserted-by":"publisher","unstructured":"Maharjan CK, Ear PH, Tran CG, Howe JR, Chandrasekharan C, Quelle DE (2021) Pancreatic neuroendocrine tumors: molecular mechanisms and therapeutic targets. Cancers (Basel) 13(20). https:\/\/doi.org\/10.3390\/cancers13205117","DOI":"10.3390\/cancers13205117"},{"issue":"7 Suppl","key":"3570_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cncr.23648","volume":"113","author":"RT Jensen","year":"2008","unstructured":"Jensen RT, Berna MJ, Bingham DB, Norton JA (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(7 Suppl):1807\u20131843. https:\/\/doi.org\/10.1002\/cncr.23648","journal-title":"Cancer"},{"issue":"2","key":"3570_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.gie.2008.04.057","volume":"69","author":"J Sreenarasimhaiah","year":"2009","unstructured":"Sreenarasimhaiah J, Armstrong LA, Tang SJ, Barnett C (2009) Pancreatic somatostatinoma and tuberous sclerosis: case report of an exceedingly rare association. Gastrointest Endosc 69(2):379\u2013381. https:\/\/doi.org\/10.1016\/j.gie.2008.04.057","journal-title":"Gastrointest Endosc"},{"issue":"15","key":"3570_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ajmg.a.31351","volume":"140","author":"JL Merritt 2nd","year":"2006","unstructured":"Merritt JL 2nd, Davis DM, Pittelkow MR, Babovic-Vuksanovic D (2006) Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations. Am J Med Genet A 140(15):1669\u20131672. https:\/\/doi.org\/10.1002\/ajmg.a.31351","journal-title":"Am J Med Genet A"},{"issue":"10","key":"3570_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/00000478-200310000-00012","volume":"27","author":"P Francalanci","year":"2003","unstructured":"Francalanci P, Diomedi-Camassei F, Purificato C et al (2003) Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol 27(10):1386\u20131389. https:\/\/doi.org\/10.1097\/00000478-200310000-00012","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3570_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4158\/EP.8.2.109","volume":"8","author":"MS Eledrisi","year":"2002","unstructured":"Eledrisi MS, Stuart CA, Alshanti M (2002) Insulinoma in a patient with tuberous sclerosis: is there an association? Endocr Pract Mar-Apr 8(2):109\u2013112. https:\/\/doi.org\/10.4158\/EP.8.2.109","journal-title":"Endocr Pract Mar-Apr"},{"issue":"4","key":"3570_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s004310051073","volume":"158","author":"S Verhoef","year":"1999","unstructured":"Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL et al (1999) Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr 158(4):284\u2013287. https:\/\/doi.org\/10.1007\/s004310051073","journal-title":"Eur J Pediatr"},{"key":"3570_CR9","unstructured":"Boubaddi NE, Imbert Y, Tissot B, et al 1997 [Secreting insulinoma and Bourneville\u2019s tuberous sclerosis]. Gastroenterol Clin Biol 21(4):343. Insulinome secretant et sclerose tubereuse de Bourneville"},{"issue":"6","key":"3570_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","volume":"82","author":"AM Larson","year":"2012","unstructured":"Larson AM, Hedgire SS, Deshpande V et al (2012) Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clin Genet 82(6):558\u2013563. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01805.x","journal-title":"Clin Genet"},{"key":"3570_CR11","doi-asserted-by":"publisher","unstructured":"Park R. Chatterjee D AM, Trikalinos N (2020) Exceptional response to neoadjuvant capecitabine and temozolomide in TSC2-mutant pancreatic neuroendocrine tumor. Current Problems in Cancer: Case Reports 2(15). https:\/\/doi.org\/10.1016\/j.cpccr.2020.100037","DOI":"10.1016\/j.cpccr.2020.100037"},{"issue":"D1","key":"3570_CR12","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC et al (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47(D1):D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gky1015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3570_CR13","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1038\/s41598-020-62759-5","volume":"10","author":"ME Reyna-Fabian","year":"2020","unstructured":"Reyna-Fabian ME, Hernandez-Martinez NL, Alcantara-Ortigoza MA et al (2020) First comprehensive TSC1\/TSC2 mutational analysis in Mexican patients with tuberous sclerosis complex reveals numerous novel pathogenic variants. Sci Rep 10(1):6589. https:\/\/doi.org\/10.1038\/s41598-020-62759-5","journal-title":"Sci Rep"},{"issue":"3","key":"3570_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12022-020-09628-z","volume":"31","author":"Y Xue","year":"2020","unstructured":"Xue Y, Reid MD, Pehlivanoglu B et al (2020) Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification. Endocr Pathol 31(3):239\u2013253. https:\/\/doi.org\/10.1007\/s12022-020-09628-z","journal-title":"Endocr Pathol"},{"issue":"1","key":"3570_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/PAS.0b013e31823d0560","volume":"36","author":"NC Arva","year":"2012","unstructured":"Arva NC, Pappas JG, Bhatla T et al (2012) Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis\u2013case report and review of the literature. Am J Surg Pathol 36(1):149\u2013153. https:\/\/doi.org\/10.1097\/PAS.0b013e31823d0560","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3570_CR16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1210\/js.2019-00051","volume":"3","author":"S Mehta","year":"2019","unstructured":"Mehta S, Rusyn L, Ginsburg H, Hajdu C, Kohn B (2019) Pancreatic neuroendocrine tumor in a young child with tuberous sclerosis complex 1. J Endocr Soc 3(6):1201\u20131206. https:\/\/doi.org\/10.1210\/js.2019-00051","journal-title":"J Endocr Soc"},{"key":"3570_CR17","doi-asserted-by":"publisher","unstructured":"Klimstra DS, Beltran H, Lilenbaum R, Bergsland E (2015) The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap. Am Soc Clin Oncol Educ Book 92\u2013103. https:\/\/doi.org\/10.14694\/EdBook_AM.2015.35.92","DOI":"10.14694\/EdBook_AM.2015.35.92"},{"issue":"6021","key":"3570_CR18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH et al (2011) DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331(6021):1199\u20131203. https:\/\/doi.org\/10.1126\/science.1200609","journal-title":"Science"},{"issue":"5","key":"3570_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","volume":"71","author":"WM Hackeng","year":"2022","unstructured":"Hackeng WM, Brosens LAA, Kim JY et al (2022) Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size. Gut 71(5):961\u2013973. https:\/\/doi.org\/10.1136\/gutjnl-2020-322595","journal-title":"Gut"},{"issue":"2","key":"3570_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","volume":"146","author":"I Marinoni","year":"2014","unstructured":"Marinoni I, Kurrer AS, Vassella E et al (2014) Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 146(2):453\u201360 e5. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.020","journal-title":"Gastroenterology"},{"issue":"6","key":"3570_CR21","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/MPA.0000000000002091","volume":"51","author":"MY Zhang","year":"2022","unstructured":"Zhang MY, He D, Zhang S, Liu JY (2022) Genetic alterations of both MEN1\/ATRX and TP53\/RB1 in pancreatic neuroendocrine neoplasms. Pancreas 51(6):e91\u2013e93. https:\/\/doi.org\/10.1097\/MPA.0000000000002091","journal-title":"Pancreas"},{"issue":"7","key":"3570_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","volume":"44","author":"M Tjota","year":"2020","unstructured":"Tjota M, Chen H, Parilla M, Wanjari P, Segal J, Antic T (2020) Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study. Am J Surg Pathol 44(7):943\u2013954. https:\/\/doi.org\/10.1097\/PAS.0000000000001457","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3570_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","volume":"43","author":"YB Chen","year":"2019","unstructured":"Chen YB, Mirsadraei L, Jayakumaran G et al (2019) Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol 43(1):121\u2013131. https:\/\/doi.org\/10.1097\/PAS.0000000000001170","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"3570_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","volume":"42","author":"DN Palsgrove","year":"2018","unstructured":"Palsgrove DN, Li Y, Pratilas CA et al (2018) Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum. Am J Surg Pathol 42(9):1166\u20131181. https:\/\/doi.org\/10.1097\/PAS.0000000000001111","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"3570_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","volume":"42","author":"M Parilla","year":"2018","unstructured":"Parilla M, Kadri S, Patil SA et al (2018) Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations? Am J Surg Pathol 42(7):911\u2013917. https:\/\/doi.org\/10.1097\/PAS.0000000000001067","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"3570_CR26","first-page":"8401","volume":"61","author":"Y Tanaka","year":"2001","unstructured":"Tanaka Y, Kato K, Notohara K et al (2001) Frequent beta-catenin mutation and cytoplasmic\/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 61(23):8401\u20138404","journal-title":"Cancer Res"},{"issue":"1","key":"3570_CR27","first-page":"5","volume":"68","author":"S Tejpar","year":"2005","unstructured":"Tejpar S, Michils G, Denys H et al (2005) Analysis of Wnt\/beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg 68(1):5\u20139","journal-title":"Acta Gastroenterol Belg"},{"key":"3570_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.humpath.2018.09.018","volume":"84","author":"H Koike","year":"2019","unstructured":"Koike H, Nishida Y, Kohno K et al (2019) Is immunohistochemical staining for beta-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study? Hum Pathol 84:155\u2013163. https:\/\/doi.org\/10.1016\/j.humpath.2018.09.018","journal-title":"Hum Pathol"},{"issue":"4","key":"3570_CR29","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1530\/ERC-17-0014","volume":"24","author":"AK Lam","year":"2017","unstructured":"Lam AK, Saremi N (2017) Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer 24(4):R109\u2013R121. https:\/\/doi.org\/10.1530\/ERC-17-0014","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"3570_CR30","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/00000478-200308000-00014","volume":"27","author":"MP Hoang","year":"2003","unstructured":"Hoang MP, Amirkhan RH (2003) Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol 27(8):1152\u20131156. https:\/\/doi.org\/10.1097\/00000478-200308000-00014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3570_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.path.2017.04.001","volume":"10","author":"E de Alava","year":"2017","unstructured":"de Alava E (2017) Ewing sarcoma, an update on molecular pathology with therapeutic implications. Surg Pathol Clin 10(3):575\u2013585. https:\/\/doi.org\/10.1016\/j.path.2017.04.001","journal-title":"Surg Pathol Clin"},{"key":"3570_CR32","doi-asserted-by":"publisher","unstructured":"Cooper GW, Hong AL (2022) SMARCB1-deficient cancers: novel molecular insights and therapeutic vulnerabilities. Cancers (Basel) 14(15).\u00a0https:\/\/doi.org\/10.3390\/cancers14153645","DOI":"10.3390\/cancers14153645"},{"issue":"2","key":"3570_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00000478-200402000-00009","volume":"28","author":"J Shia","year":"2004","unstructured":"Shia J, Guillem JG, Moore HG et al (2004) Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28(2):215\u2013223. https:\/\/doi.org\/10.1097\/00000478-200402000-00009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3570_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/PAS.0b013e318200cf78","volume":"35","author":"J Shia","year":"2011","unstructured":"Shia J, McManus M, Guillem JG et al (2011) Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35(1):127\u2013134. https:\/\/doi.org\/10.1097\/PAS.0b013e318200cf78","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3570_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/modpathol.2017.87","volume":"31","author":"RK Pai","year":"2018","unstructured":"Pai RK, Pai RK (2018) Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy. Mod Pathol 31(1):4\u201323. https:\/\/doi.org\/10.1038\/modpathol.2017.87","journal-title":"Mod Pathol"},{"issue":"2","key":"3570_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"issue":"3","key":"3570_CR37","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1530\/ERC-13-0365","volume":"21","author":"L de Mestier","year":"2014","unstructured":"de Mestier L, Dromain C, d\u2019Assignies G et al (2014) Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art. Endocr Relat Cancer 21(3):R105\u2013R120. https:\/\/doi.org\/10.1530\/ERC-13-0365","journal-title":"Endocr Relat Cancer"},{"key":"3570_CR38","doi-asserted-by":"publisher","unstructured":"Kunz PL, Graham NT, Catalano PJ et al (2022) A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors (ECOG-ACRIN E2211). J Clin Oncol 101200JCO2201013. https:\/\/doi.org\/10.1200\/JCO.22.01013","DOI":"10.1200\/JCO.22.01013"},{"issue":"4","key":"3570_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000342270","volume":"96","author":"A Sundin","year":"2012","unstructured":"Sundin A, Rockall A (2012) Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology 96(4):261\u2013271. https:\/\/doi.org\/10.1159\/000342270","journal-title":"Neuroendocrinology"},{"issue":"3","key":"3570_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s11154-021-09645-1","volume":"22","author":"MP Vullierme","year":"2021","unstructured":"Vullierme MP, Ruszniewski P, de Mestier L (2021) Are recist criteria adequate in assessing the response to therapy in metastatic NEN? Rev Endocr Metab Disord 22(3):637\u2013645. https:\/\/doi.org\/10.1007\/s11154-021-09645-1","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"3570_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-017-0596-2","volume":"12","author":"DN Franz","year":"2017","unstructured":"Franz DN, Capal JK (2017) mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders. Orphanet J Rare Dis 12(1):51. https:\/\/doi.org\/10.1186\/s13023-017-0596-2","journal-title":"Orphanet J Rare Dis"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03570-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T10:18:42Z","timestamp":1691576322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03570-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03570-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript meets ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}